Literature DB >> 12662357

Susceptibility of human and murine Chlamydia trachomatis serovars to granulocyte- and epithelium-derived antimicrobial peptides.

C Chong-Cerrillo1, M E Selsted, E M Peterson, L M de la Maza.   

Abstract

Four antimicrobial peptides, protegrin-1, RTD-1, cryptdin-4, and indolicidin, were tested for their ability to inhibit the in vitro growth of Chlamydia trachomatis serovars E, L2, and mouse pneumonitis (MoPn). In general, protegrin-1 was found to have the strongest anti-chlamydial activity. Overall, of the three serovars tested, L2 was the most susceptible while MoPn was the most resistant to these peptides.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12662357     DOI: 10.1034/j.1399-3011.2003.00053.x

Source DB:  PubMed          Journal:  J Pept Res        ISSN: 1397-002X


  12 in total

1.  Susceptibility of Chlamydia trachomatis to excipients commonly used in topical microbicide formulations.

Authors:  M F Lampe; L C Rohan; M C Skinner; W E Stamm
Journal:  Antimicrob Agents Chemother       Date:  2004-08       Impact factor: 5.191

2.  An antibody as surrogate receptor reveals determinants of activity of an innate immune peptide antibiotic.

Authors:  Suvendu Lomash; Sushma Nagpal; Dinakar M Salunke
Journal:  J Biol Chem       Date:  2010-09-13       Impact factor: 5.157

3.  Retrocyclins kill bacilli and germinating spores of Bacillus anthracis and inactivate anthrax lethal toxin.

Authors:  Wei Wang; Chandrika Mulakala; Sabrina C Ward; Grace Jung; Hai Luong; Duy Pham; Alan J Waring; Yiannis Kaznessis; Wuyuan Lu; Kenneth A Bradley; Robert I Lehrer
Journal:  J Biol Chem       Date:  2006-06-21       Impact factor: 5.157

4.  Activity of cathelicidin peptides against Chlamydia spp.

Authors:  Manuela Donati; Korinne Di Leo; Monica Benincasa; Francesca Cavrini; Silvia Accardo; Alessandra Moroni; Renato Gennaro; Roberto Cevenini
Journal:  Antimicrob Agents Chemother       Date:  2005-03       Impact factor: 5.191

5.  Role of matrix metalloproteinase-7 in the modulation of a Chlamydia trachomatis infection.

Authors:  Sukumar Pal; Amy P Schmidt; Ellena M Peterson; Carole L Wilson; Luis M de la Maza
Journal:  Immunology       Date:  2006-02       Impact factor: 7.397

6.  Peptide-based Antifungal Therapies against Emerging Infections.

Authors:  A Matejuk; Q Leng; M D Begum; M C Woodle; P Scaria; S-T Chou; A J Mixson
Journal:  Drugs Future       Date:  2010-03       Impact factor: 0.148

Review 7.  Chlamydial Plasmid-Dependent Pathogenicity.

Authors:  Guangming Zhong
Journal:  Trends Microbiol       Date:  2016-10-03       Impact factor: 17.079

8.  The cell-penetrating peptide, Pep-1, has activity against intracellular chlamydial growth but not extracellular forms of Chlamydia trachomatis.

Authors:  Narae Park; Kinrin Yamanaka; Dat Tran; Pete Chandrangsu; Johnny C Akers; Jessica C de Leon; Naomi S Morrissette; Michael E Selsted; Ming Tan
Journal:  J Antimicrob Chemother       Date:  2008-10-27       Impact factor: 5.790

9.  Activity of Cathelicidin Peptides against Simkania negevensis.

Authors:  Manuela Donati; Antonietta Di Francesco; Maria Di Paolo; Natascia Fiani; Monica Benincasa; Renato Gennaro; Paola Nardini; Claudio Foschi; Roberto Cevenini
Journal:  Int J Pept       Date:  2011-04-05

10.  Covalent binding of the natural antimicrobial peptide indolicidin to DNA abasic sites.

Authors:  Christophe Marchand; Krzysztof Krajewski; Hsiu-Fang Lee; Smitha Antony; Allison A Johnson; Ronak Amin; Peter Roller; Mamuka Kvaratskhelia; Yves Pommier
Journal:  Nucleic Acids Res       Date:  2006-09-22       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.